Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
751.00    12.50 (1.69%)
Bid:
748.00
Ask:
751.00
Spread: 3.00 (0.401%)
Market Cap: £855.69m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Proposed Share Premium Cancellation

11 Sep 2025 08:00

RNS Number : 8691Y
Fevertree Drinks PLC
11 September 2025
Β 

11 September 2025

Β 

Fevertree Drinks plc

Β ("Fever-Tree" or the "Company")

Β 

Proposed Share Premium Cancellation and Notice of General Meeting

Further to the announcement of its FY25 Interim Results this morning, Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that its Notice of General Meeting (the Circular) is now available to view on the Company's website atΒ www.fever-tree.com/investorsΒ and will be posted today to those Shareholders who elected to receive a paper copy.

The Circular contains details of a proposed cancellation of the Company's share premium account (the Share Premium Cancellation). The Share Premium Cancellation is proposed to be undertaken to create further distributable reserves to support: (i) further share buybacks; (ii) the future payment by the Company of dividends to its Shareholders (in each case should circumstances dictate it appropriate or desirable to do so); and (iii) for other corporate purposes of the Company. Β 

Capitalised terms in this announcement have the meaning given to them in the Circular.

The Share Premium Cancellation is conditional upon the passing of the special resolution set out in the Notice of General Meeting by the Company's Shareholders, as well as approval being obtained by the Court. It is expected that the final hearing of the application will take place on 11 November 2025. The Effective Date of the Share Premium Cancellation is expected to be on or around 12 November 2025 but will depend on, amongst other things, the date on which the Court confirms the Share Premium Cancellation.

Completion of the Share Premium Cancellation will not affect the rights attached to the Ordinary Shares and will not result in any change to the number of Ordinary Shares in issue (or their nominal value).

The General Meeting will be held at the office of Reynolds Porter Chamberlain LLP, Tower Bridge House, St Katharine's Way, London E1W 1AA on 17 October 2025 at 11:00 a.m.

If you plan to attend the General Meeting in person, Shareholders are encouraged to notify the Company in advance by email to legal@fever-tree.com to assist us in planning and implementing arrangements for the General Meeting.

Β 

Ends

Β 

For further information:

Β 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 7951 849564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

Β 

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

Corporate Broker - Jefferies International Limited

Ed Matthews I Richard Taylor I +44 (0)20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan +44 (0)7826 534 233

Β 

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCBBLLFEKLLBBQ
Date   Source Headline
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20269:35 amRNSTotal Voting Rights
27th May 20267:00 amRNSTransaction in Own Shares
22nd May 20269:51 amRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20264:00 pmRNSGrant of Options
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20265:35 pmRNSDividend Timetable Update
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20265:11 pmRNS2025 Annual Report and Notice of AGM
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202611:02 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSFY25 Preliminary Results to 31 December 2025
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20262:47 pmRNSTotal Voting Rights
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.